Sep 10, 2019 

LyseNTech completed MTA and CDA with Y-Biologics to develop advanced anticancer phage technology.

Y-Biologics is a Korean biotech company focusing on the discovery & development of novel antibody therapeutics based on its human antibody library and Bi-specific antibody platform technology.